Academical Hospital, Department of Oncology
Welcome,         Profile    Billing    Logout  
 5 Trials 
8 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Lindman, Henrik
ASF-BC, NCT06152471: Effect of Salovum™ and SPC-Flakes™ on Abemaciclib-induced Gastrointestinal Toxicity in Early Breast Cancer

Recruiting
3
100
Europe
SPC-flakes, Salovum, Placebo
Henrik Lindman
Early-stage Breast Cancer, Diarrhea, Adverse Drug Event
10/24
03/25
NBG-19-01, NCT04335669: NordicTrip, a Translational Study of Preoperative Chemotherapy in TNBC

Recruiting
3
325
Europe
epirubicin, cyclophosphamide, paclitaxel, carboplatin, pembrolizumab, anthracycline, taxane, platinum, epirubicin, cyclophosphamide, capecitabine, paclitaxel, carboplatin, pembrolizumab, anthracycline, taxane, antimetabolite, platinum
Lund University Hospital, Swedish Breast Cancer Group, Danish Breast Cancer Cooperative Group
Breast Cancer, Triple Negative Breast Neoplasms
07/25
06/35
SWE-Switch, NCT06223698: Optimizing Extended Adjuvant Endocrine Therapy in Patients With Breast Cancer

Not yet recruiting
3
3832
Europe
Letrozole, Anastrozole, Exemestane, Tamoxifen
Region Örebro County, Mid-Sweden Regional Cancer Centre, Akademiska University Hospital, Uppsala, Sweden
Breast Cancer
05/32
05/35
NCT03646955: Partial Breast Versus no Irradiation for Women With Early Breast Cancer

Recruiting
3
926
Europe, RoW
No partial breast irradiation
Danish Breast Cancer Cooperative Group, Danish Cancer Society, Danish Center for Interventional Research in Radiation Oncology (CIRRO)
Local Neoplasm Recurrence, Distantly Metastatic Malignant Neoplasm, Death, Fibrosis Breast, Depigmentation/Hyperpigmentation of Skin, Telangiectasia, Scar, Pain, PROMs
09/33
09/35
ASCAPE, NCT04879563: Artificial Intelligence Supporting CAncer Patients Across Europe - the Project

Active, not recruiting
2
500
Europe
ASCAPE-based follow-up strategy
Region Örebro County, UBITECH, ATOS, Siemens Corporation, Corporate Technology, Intrasoft, University of Patras, FORTH - Foundation for Research and Technology Hellas, Sphynx Technology Solutions AG, Faculty of Sciences, University of Novi Sad, Serbia, DFKI - German Research Center for Artificial Intelligence, CareAcross, National and Kapodistrian University of Athens, Greece, Fundacio Clinic Barcelona, Arthur's Legal, Fundacion iSYS
Breast Cancer, Prostate Cancer, Quality of Life, Survivorship, Toxicity
06/24
06/24
ARIADNE, NCT05900206: Trastuzumab Deruxtecan Versus Standard Neoadjuvant Treatment for HER2-positive Breast Cancer

Recruiting
2
370
Europe
Trastuzumab deruxtecan, T-DXd, Enhertu, Docetaxel, Paclitaxel, Carboplatin, Trastuzumab, Herceptin, Pertuzumab, PErjeta, Ribociclib, Kisqali, Letrozole, Epirubicin, Cyclophosphamide
Karolinska University Hospital
Breast Cancer
04/27
04/32
Affibody-3, NCT03655353 / 2017-002115-34: A Study of 68Ga-ABY-025 PET for Non-invasive Quantification of HER2-expression in Advanced Breast Cancer

Recruiting
N/A
160
Europe
ABY-PET
Henrik Lindman, Roche Pharma AG, Swedish Cancer Society, Affibody, Swedish Breast Cancer Group
HER2-positive Breast Cancer
11/24
11/25
Einbeigi, Zakaria
NBG-19-01, NCT04335669: NordicTrip, a Translational Study of Preoperative Chemotherapy in TNBC

Recruiting
3
325
Europe
epirubicin, cyclophosphamide, paclitaxel, carboplatin, pembrolizumab, anthracycline, taxane, platinum, epirubicin, cyclophosphamide, capecitabine, paclitaxel, carboplatin, pembrolizumab, anthracycline, taxane, antimetabolite, platinum
Lund University Hospital, Swedish Breast Cancer Group, Danish Breast Cancer Cooperative Group
Breast Cancer, Triple Negative Breast Neoplasms
07/25
06/35

Download Options